Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Atlas Volumetric Dosing System

Product Description

atlas_volumetric_dosing_system.jpg

The Atlas Syringe Pump is a versatile volumetric dosing and/or sampling system. It allows 2 independent refilling flows, one continuous flow, reaction sampling, intelligent control of pH and temperature dependant dosing. It consists of two syringes and multi port valves and can be controlled from the front panel, by the Reactor Master, an Atlas Base or PC software.

Atlas from Syrris is a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Designed specifically for ease of use, all Atlas chemical reactors can be scaled in 3 ways: by volume, automation level, and number of reactions.

What’s more, it’s extremely fast and easy to change configuration from one to another without tools. All of the systems are highly chemically resistant and automated synthesis can be controlled by the hardware or PC software.

Features & Benefits

Flexible: Use as 2 refilling pump channels or 1 continuous pump channel or an autosampler.

Easy to use on its own: Twist and click control knob and large display.

Automated reagent addition: Dispense simply by volume or flow rate over a time period or create advanced flow profiles.

Versatile: 10 reagents to one reactor, 1 reagent to 10 reactors, 5 reagents to 2 reactors, one continuous flow, etc.

Automated reaction sampling: Use with the Autosampler module to regularly aspirate samples into 2ml HPLC vials.

Wide flow rate range: 0.5 l/min to 10ml/min (up to 100ml/min with the Atlas Syringe Pump XL)

Intelligent: Pump to control pH or pause if a reaction temperature is exceeded. Full data logging to a csv file.

Compact size: Fits conveniently alongside reactor. Excellent chemical compatibility: PTFE, PCTFE and glass.

Product Atlas Volumetric Dosing System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992
Email: info@syrris.com



Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!